Why Is Zoom (ZM) Down 2.1% Since Last Earnings Report?

Zoom's fiscal Q2 2027 adjusted EPS of $1.55 beat consensus by 12.3%, while revenue rose 4.9% year over year to $1.28B and exceeded estimates by 1.3%. Enterprise revenue grew 7.8%, but online revenue increased just 0.6% and non-GAAP operating margin fell 130bps to 40.0%. Zoom reaffirmed FY2027 revenue guidance of $5.085B-$5.095B and EPS of $6.08-$6.12, while analyst estimates have trended lower and shares have declined 2.1% since earnings.

Analysis

The relevant setup is not a demand-collapse short; it is a valuation-duration problem. ZM is funding AI/CX expansion while its core installed base is essentially mature, so incremental AI revenue must arrive quickly enough to offset both slower self-serve monetization and operating-margin dilution. A sub-100% enterprise expansion rate means the enterprise cohort is not yet producing the seat/price expansion needed for a durable re-rating; paid-AI adoption metrics are encouraging but remain company-reported usage indicators rather than disclosed ARR or attach-rate economics.

Over the next 1-3 months, downward estimate revisions can keep the stock capped even if the next print meets guidance: the market will likely require evidence that AI products are increasing net retention, not merely bundled into renewals. The buyback provides a floor only if repurchases remain meaningfully accretive relative to cash generation; declining free-cash-flow conversion and sustained margin erosion would weaken that support. Competitive pressure is asymmetric: MSFT can bundle Teams/Copilot across a broader enterprise suite, while CRM, NICE and FIVE9 have more established contact-center distribution, raising customer-acquisition costs for Zoom's CX ambitions.

The contrarian opportunity is that the market may be underpricing strategic optionality from the cash balance and the possibility that AI agents convert Zoom from a collaboration vendor into a customer-engagement platform. That requires measurable acceleration in enterprise expansion, AI ARR disclosure, or a material acquisition/capital-return decision over 6-18 months. Until then, the cleaner expression is relative rather than outright: ZM's cash-backed downside is real, but its catalyst path is weaker than software peers already showing AI monetization in reported contract value.

Key Decisions for Investors

• Maintain a neutral-to-underweight ZM stance into the next earnings release; avoid adding on a modest post-earnings beat unless management raises full-year revenue or operating-income guidance. Thesis is falsified by enterprise net retention moving sustainably above 102% alongside disclosed paid-AI ARR/attach-rate acceleration.
• Use a 1-3 month pair trade: long MSFT / short ZM in equal beta-adjusted dollars. MSFT has greater bundling leverage and monetization evidence; risk is a discrete ZM AI-CX contract announcement or an accelerated repurchase/tender. Cover the ZM leg if it outperforms MSFT by 10% without a corresponding estimate upgrade.
• Monitor ZM for a 6-18 month long entry only if free-cash-flow guidance stabilizes or rises while AI investment does not further compress operating margin. A credible catalyst would be separately reported AI/CX ARR sufficient to support a return to mid-single-digit or better consolidated growth.
• Do not treat the remaining repurchase authorization as a standalone bullish catalyst. Reassess capital-return support after the next quarterly cash-flow statement; continued cash-balance decline without per-share FCF growth would shift buybacks from valuation support to evidence of limited organic deployment opportunities.